Peptide Nucleic Acids Targeted to the Amyloid Precursor Protein

Journal of Molecular Neuroscience

Volumn 20, Issue 3, 2003, Pages 261-265

  McMahon, Beth M ^a,b   Stewart, Jennifer ^a   Fauq, Abdul ^a   Younkin, Steven ^a   Younkin, Linda ^a   Richelson, Elliott ^a  

^a MAYO CLINIC   (United States)

^b Genteric Inc   (United States)

Author keywords

Antigene; Antisense; Mouse; Rat

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; BETA SECRETASE; BRAIN PROTEIN; MESSENGER RNA; OLIGONUCLEOTIDE; PEPTIDE NUCLEIC ACID; UNCLASSIFIED DRUG; AMYLOID BETA PROTEIN (1 42); AMYLOID BETA-PROTEIN (1-42); ASPARTIC PROTEINASE; PEPTIDE FRAGMENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN LEVEL; CONTROLLED STUDY; EXPERIMENT; INHIBITION KINETICS; LABORATORY; MOLECULE; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN TARGETING; RAT; RNA TRANSLATION; ALZHEIMER DISEASE; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; DOWN REGULATION; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; METABOLISM; NUCLEIC ACID PROBE; PHYSIOLOGY; PROTEIN SYNTHESIS;

ANIMALIA;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; ANTISENSE ELEMENTS (GENETICS); ASPARTIC ENDOPEPTIDASES; DOWN-REGULATION; MICE; MICE, INBRED C57BL; PEPTIDE FRAGMENTS; PEPTIDE NUCLEIC ACIDS; PROTEIN BIOSYNTHESIS; RATS; RNA, MESSENGER;

EID: 0642340256     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1385/JMN:20:3:261     Document Type: Article

References (20)

1. Boffa L. C., Scarfi S., Mariani M. R., Damonte G., Allfrey V. G., Benatti U., and Morris P. L. (2000) Dihydrotestosterone as a selective cellular/nuclear localization vector for anti-gene peptide nucleic acid in prostatic carcinoma cells. Cancer Res. 60, 2258-2262.
2. Corey D. R. (1997) Peptide nucleic acids: expanding the scope of nucleic acid recognition. Trends Biotechnol. 15, 224-229.
3. Cutrona G., Carpaneto E. M., Ulivi M., Roncella S., Landt O., Ferrarini M., and Boffa L. C. (2000) Effects in live cells of a c-myc anti-gene PNAlinked to a nuclear localization signal. Nat. Biotechnol. 18, 300-303.
4. Demidov V. V., Potaman V. N., Frank-Kamenetskii M. D., Egholm M., Buchara O., Sonnichsen S. H., and Nielsen P. E. (1994) Stability of peptide nucleic acids in human serum and cellular extracts. Biochem. Pharmacol. 48, 1310-1313.
5. Dias N., Dheur S., Nielsen P. E., Gryaznov S., Van Aerschot A., Herdewijn P., Helene C., and Saison-Behmoaras T. E. (1999) Antisense PNA tridecamers targeted to the coding region of Ha-ras mRNA arrest polypeptide chain elongation. J. Mol. Biol. 294, 403-416.
6. Hardy J. (1997) Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci. 20, 154-159.
7. Kurg R., Langel U., and Ustav M. (2000) Inhibition of the bovine papillomavirus E2 protein activity by peptide nucleic acid. Virus Res. 66, 39-50.
8. McMahon B. M., Stewart J., Fauq A., Younkin S., Younkin L., and Richelson E. (2002a) Using peptide nucleic acids as gene-expression modifiers to reduce beta-amyloid levels. J. Mol. Neurosci. 19, 71-76.
9. McMahon B. M., Stewart J. A., Bitner M. D., Fauq A., McCormick D. J., and Richelson E. (2002b) Peptide nucleic acids specifically cause antigene effects in vivo by systemic injection. Life Sci. 71, 325-337.
10. McMahon B. M., Stewart J. A., Jackson J., Fauq A., McCormick D. J., and Richelson E. (2001) Intraperitoneal injection of antisense peptide nucleic acids targeted to the mu receptor decreases response to morphine and receptor protein levels in rat brain. Brain Res. 904, 345-349.
11. Nielsen P. E. (2000) Antisense properties of peptide nucleic acid. Antisense Technol. A. 313, 156-164.
12. Nielsen P. E., Egholm M., Berg R. H., and Buchardt O. (1993) Peptide nucleic acids (PNAs): potential antisense and anti-gene agents. Anticancer Drug Des. 8, 53-63.
13. Pooga M., Soomets U., Hallbrink M., Valkna A., Saar K., Rezaei K., et al. (1998) Cell penetrating PNA constructs regulate galanin receptor levels and modify pain transmission in vivo. Nat. Biotechnol. 16, 857-861.
14. Rezaei K., Xu I. S., Wu W. P., Shi T. J., Soomets U., Land T., et al. (2001) Intrathecal administration of PNA targeting galanin receptor reduces galanin-mediated inhibitory effect in the rat spinal cord. Neuroreport 12, 317-320.
15. Scheuner D., Eckman C., Jensen M., Song X., Citron M., Suzuki N., et al. (1996) Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat. Med. 2, 864-870.
16. Suzuki, N., Cheung, T. T., Cai, X. D., Odaka, A., Otvos L., Jr., Eckman C., et al. (1994) An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants. Science 264, 1336-1340.
17. Tyler B. M., Jansen K., McCormick D. J., Douglas C. L., Boules M., Stewart J. A., et al. (1999) Peptide nucleic acids targeted to the neurotensin receptor and administered i.p. cross the blood-brain barrier and specifically reduce gene expression. Proc. Natl. Acad. Sci. USA 96, 7053-7058.
18. Tyler-McMahon B. M., Stewart J. A., Jackson J., Bitner M. D., Fauq A., McCormick D. J., and Richelson E. (2001) Altering behavioral responses and dopamine transporter protein with antisense peptide nucleic acids. Biochem. Pharmacol. 62, 929-932.
19. Vassar R., Bennett B. D., BabuKhan S., Kahn S., Mendiaz E. A., Denis P., et al. (1999) Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286, 735-741.
20. Villa R., Folini M., Lualdi S., Veronese S., Daidone M. G., and Zaffaroni N. (2000) Inhibition of telomerase activity by a cell-penetrating peptide nucleic acid construct in human melanoma cells. FEBS Lett. 473, 241-248.